Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

NPA partners with Mind to raise awareness of pharmacy services for people with mental health issues

The National Pharmacy Association (NPA) has been partnered with Mind to raise funds for the charity's vital work as well as to raise awareness of pharmacy services for people with mental health problems.

The initiative is being launched as part of the NPA’s centenary celebrations which will include fundraising activities around a ‘100’ theme, for example 100 mile (or 100 metre!) walks and 100 question quizzes.


“All pharmacists, colleagues, family and friends are being invited to participate – either by supporting the NPA’s own set-piece events, or by organising their own activities,” the NPA said in a statement on Thursday (May 13).

“As a pillar of communities across the UK, pharmacies often take part in charitable fundraising and engage with the voluntary sector in a variety of ways. It can have a positive impact on the reputation of a business and also improves staff morale.”

The NPA will will be working alongside Mind in England and Wales, and its sister charities in Scotland and Northern Ireland, Scottish Association for Mental Health (SAMH), and Inspire Wellbeing.

NPA board member, Raj Aggarwal OBE, said: “I am personally looking forward to getting stuck into fundraising activities. Community pharmacy is well placed at the heart of local communities to identify and help those in need of support to maintain good mental health. Our message is that community pharmacies are concerned with the wellbeing of the whole person – mind as well as body.”

Emma Ihsan, head of corporate partnerships at Mind, said: “We are incredibly grateful to the National Pharmacy Association for choosing to mark its 100th year by raising funds to support people experiencing mental health problems in the UK.

“During the pandemic, millions of us have experienced a mental health problem, or seen a loved one struggle for the first time in our lives, and Mind’s services have never been more in demand. The funds donated by the NPA will help us be there for as many people who need us as possible and will help Mind to fight for change, for fairness, for respect and for life-changing support.”

Sinead O’Dwyer, corporate partnerships fundraiser at SAMH, said: “At SAMH, we know how a mental health problem can affect everything. It can have the most profound impact on our relationships, our work, our wellbeing and our quality of life. Our partnership with the National Pharmacy Association will fund crucial mental health support for people across Scotland.

“On behalf of everyone at SAMH, a huge thank you to the NPA and their members. We are proud to be your partner and know you are all equally as proud to support the mental health cause. We look forward to working together to make a real difference – here’s to a fantastic partnership!”

Kerry Anthony MBE, CEO of Inspire, said: “We are delighted to be partnering with the National Pharmacy Association in this their 100th year anniversary. Pharmacies are at the heart of communities across the country and for over 60 years Inspire has been a beacon of hope for those living with mental ill health and addictions in the same communities.

"We look forward to working with all our community pharmacies in Northern Ireland, raising funds, awareness, spreading a message of positive mental health and wellbeing."

More For You

NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less